The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Kevin Joseph, PharmD Candidate
Advertisement
Articles by Kevin Joseph, PharmD Candidate
Advertisement
Latest Updated Articles
- New FDA Actions: UCB's Neupro
Published: July 10th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
5
